The very cream of market veterans with decades of street cred share their invaluable perspective and analysis.
Managing partner at Pacific Paradigm Advisors Punita Kumar Sinha talk about Global Trade Tide over Trump and U.S. tech stocks.
Nilesh Shah, MD, Kotak Mahindra Asset Management talks about the balanced funds witnessing some outflows in the last few months.
Chief Investment Officer of Ashburton Investments Jonathan Schiessl talk about volatile markets and India's macro concerns.
Anil Ahuja, IPEplus Advisors talks about the possibility of of the second half year belonging to the pharma.
Anil Ahuja. CEO, IPE plus Advisors, discusses about both I.T. and Pharma Gaining Substantially On Back Of Strong $.
Mahantesh Sabarad, SBICAP Securities talks about rise and fall of sector stocks, long term capital gain tax churning and mutual fund portfolio.
VK Sharma, HDFC Securities talks about the earnings growth for Sun Pharma and also the new market highs by year end.
Andrew Holland, CEO, Avendus Capital talks about the market setup for the next few months with influential factors like the monsoon.
Deven Choksey,MD, KR Choksey says valuations will remain expensive as earnings growth is at a high of 15-20%
Minority investors divided over changes at ICICI bank
Fund managers seek clarity on governance & leadership for investment decisions
Kochhar's fully paid leave raises questions
Proxy advisory firm raises questions on remuneration
Will issue 5.1% equity shares worth Rs 746 Cr to investors, priced at Rs 1,661/sh
IIFL's wealth management business valued at Rs 14,600 Cr
Investors include Amansa holdings, General Atlantic Singapore & HDFC Standard Life
Gets final USFDA approval for Generic Sustiva
U.S. Sales stood at approximately $105 Mn in a 12 month period, ending in April 2018
Nerolac to enter share purchase agreement with RAK paints in Bangladesh
Will acquire 55% paid up equity share capital in RAK paints for Rs 45.8 Cr
Acquisition to be complete by 31st July 2018
UPL consortium said to be in talks to buy platform's agri pesticide unit Arysta Lifescience
UPL to team up with Abu Dhabi investment authority for Arysta Lifescience
UPL group's talks for Arysta Lifescience unit said to be in advanced stages